CEN Biotech, Inc.
CENBF
$0.0001
$0.000.00%
09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 148.20K | 66.00K | 135.20K | 193.20K | 213.80K |
Total Receivables | 45.70K | 139.30K | 199.10K | 228.50K | 164.40K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 106.70K | 39.80K | 49.60K | 50.50K | 18.70K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 300.50K | 245.10K | 383.90K | 472.20K | 396.90K |
|
|||||
Total Current Assets | 300.50K | 245.10K | 383.90K | 472.20K | 396.90K |
Net Property, Plant & Equipment | 164.10K | 189.30K | 212.60K | 235.50K | 254.10K |
Long-term Investments | 1.28M | 1.31M | 1.31M | 1.31M | 1.13M |
Goodwill | 1.28M | 1.31M | 1.31M | 1.31M | 1.13M |
Total Other Intangibles | 4.82M | 4.97M | 4.99M | 5.07M | 5.28M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.35M | 1.35M | 1.43M | 1.35M | 1.34M |
Total Assets | 7.91M | 8.07M | 8.32M | 8.44M | 8.40M |
|
|||||
Total Accounts Payable | 450.70K | 471.90K | 476.20K | 541.80K | 345.30K |
Total Accrued Expenses | 3.81M | 3.73M | 4.07M | 3.87M | 3.96M |
Short-term Debt | 3.25M | 3.25M | 3.25M | 3.25M | 3.55M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.18M | 2.13M | 2.06M | 2.05M | 3.02M |
Total Finance Division Other Current Liabilities | 141.20K | 145.30K | 145.30K | 145.30K | -- |
Total Other Current Liabilities | 141.20K | 145.30K | 145.30K | 145.30K | -- |
Total Current Liabilities | 9.83M | 9.73M | 10.01M | 9.86M | 10.87M |
|
|||||
Total Current Liabilities | 9.83M | 9.73M | 10.01M | 9.86M | 10.87M |
Long-Term Debt | 30.60K | 31.60K | 47.40K | 31.60K | 31.40K |
Short-term Debt | 3.25M | 3.25M | 3.25M | 3.25M | 3.55M |
Capital Leases | 159.50K | 174.10K | 188.10K | 206.80K | 224.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 354.90K |
Total Liabilities | 10.02M | 9.93M | 10.24M | 10.10M | 11.48M |
|
|||||
Common Stock & APIC | 44.92M | 44.75M | 44.34M | 44.34M | 40.86M |
Retained Earnings | -46.99M | -46.57M | -46.22M | -45.96M | -43.90M |
Treasury Stock & Other | -35.80K | -35.80K | -35.80K | -33.90K | -44.40K |
Total Common Equity | -2.11M | -1.86M | -1.92M | -1.66M | -3.08M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.11M | -1.86M | -1.92M | -1.66M | -3.08M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.11M | -1.86M | -1.92M | -1.66M | -3.08M |
|